Centers for Disease Control and Prevention (CDC). U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR 44(RR-7), 1995.

Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, Jimenez E, O'Neill E, Bazin B, Delfraissy JF, Culnane M, Coombs R, Elkins M, Moye J, Stratton P, Balsley J. Reduction of material—infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331(18):173–1180, 1994.


Etzioni A. HIV testing of infants: privacy and public health. When does preserving the right to privacy jeopardize the life of an infant? The policy debate heats up . Health Affairs 17:170–183, 1998.


Levin BW, Krantz DH Jr., Driscoll JM, Fleischman AR. The treatment of non-HIV-related conditions in newborns at risk for HIV: A survey of neonatologists. Am J Publ Health 85(11):1507–1513, 1995.

Workshop Agenda

Washington, D.C.

February 11, 1998

9:00–9:15 a.m.

Welcome and introductions

9:15–11:00

Scientific and clinical perspectives on the efficacy of interventions for pregnant women and newborns and the accuracy of HIV testing

 

Counseling, testing, diagnosis of HIV infection in pregnant women

 

Ruth Tuomala

 

Determinants of vertical transmission and efficacy of preventive strategies, including retrovirals

 

Lynne Mofenson

 

Diagnosis, viral and immunopathogenesis, and therapy in the newborn

 

Catherine Wilfert

11:00–11:15

Break

11:15–1:00 p.m.

Institutional positions regarding prenatal/newborn HIV testing and counseling

 

Public Health Service

 

Martha Rogers

 

American Medical Association

 

John Henning



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement